Yakisich JS[au] - Search Results

Year	Number of Results
1994	1
1995	1
1998	2
1999	2
2001	1
2002	1
2004	2
2005	1
2006	2
2009	3
2010	4
2011	4
2012	5
2013	1
2014	6
2015	2
2016	8
2017	11
2018	3
2019	3
2020	2
2021	3
2022	0

1

Rationale for the use of sphingosine analogues in COVID-19 patients.

Tasat DR, Yakisich JS. Tasat DR, et al. Among authors: yakisich js. Clin Med (Lond). 2021 Jan;21(1):e84-e87. doi: 10.7861/clinmed.2020-0309. Epub 2020 Nov 3. Clin Med (Lond). 2021. PMID: 33144402 Free PMC article. Review.

2

Translational gap in glioma research.

Ma C, Zhao G, Cruz MH, Siden A, Yakisich JS. Ma C, et al. Among authors: yakisich js. Anticancer Agents Med Chem. 2014;14(8):1110-20. doi: 10.2174/1871520614666140825110907. Anticancer Agents Med Chem. 2014. PMID: 25175687 Review.

3

Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers.

Kaushik V, Yakisich JS, Kumar A, Azad N, Iyer AKV. Kaushik V, et al. Among authors: yakisich js. Cancers (Basel). 2018 Sep 27;10(10):360. doi: 10.3390/cancers10100360. Cancers (Basel). 2018. PMID: 30262730 Free PMC article. Review.

4

Electrical Impedance Spectroscopy for Monitoring Chemoresistance of Cancer Cells.

Crowell LL, Yakisich JS, Aufderheide B, Adams TNG. Crowell LL, et al. Among authors: yakisich js. Micromachines (Basel). 2020 Aug 31;11(9):832. doi: 10.3390/mi11090832. Micromachines (Basel). 2020. PMID: 32878225 Free PMC article. Review.

5

Translational gap in ongoing clinical trials for glioma.

Guishard AF, Yakisich JS, Azad N, Iyer AKV. Guishard AF, et al. Among authors: yakisich js. J Clin Neurosci. 2018 Jan;47:28-42. doi: 10.1016/j.jocn.2017.10.001. Epub 2017 Oct 21. J Clin Neurosci. 2018. PMID: 29066236 Free PMC article. Review.

6

Alternative models of cancer stem cells: The stemness phenotype model, 10 years later.

Kaushik V, Kulkarni Y, Felix K, Azad N, Iyer AKV, Yakisich JS. Kaushik V, et al. Among authors: yakisich js. World J Stem Cells. 2021 Jul 26;13(7):934-943. doi: 10.4252/wjsc.v13.i7.934. World J Stem Cells. 2021. PMID: 34367485 Free PMC article. Review.

7

Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents.

Sun H, Wang Z, Yakisich JS. Sun H, et al. Among authors: yakisich js. Anticancer Agents Med Chem. 2013 Sep;13(7):1048-56. doi: 10.2174/18715206113139990130. Anticancer Agents Med Chem. 2013. PMID: 23293890 Review.

8

Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.

Wang Z, Sun H, Yakisich JS. Wang Z, et al. Among authors: yakisich js. Anticancer Agents Med Chem. 2014;14(8):1085-93. doi: 10.2174/18715206113139990029. Anticancer Agents Med Chem. 2014. PMID: 23092271 Review.

9

System models, assays and endpoint parameters to evaluate anticancer compounds during preclinical screening.

Yakisich JS. Yakisich JS. Curr Med Chem. 2014;21(35):3985-98. doi: 10.2174/09298673113209990009. Curr Med Chem. 2014. PMID: 23701499 Review.

10

One Step Histological Detection and Staining of the PTEN Tumor Suppressor Protein by a Single Strand DNA.

Longinotti G, Ybarra G, Vighi S, Perandones C, Montserrat J, Yakisich JS, Grasselli M, Radrizzani M. Longinotti G, et al. Among authors: yakisich js. Diagnostics (Basel). 2021 Jan 26;11(2):171. doi: 10.3390/diagnostics11020171. Diagnostics (Basel). 2021. PMID: 33530289 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results